Ceribell
Michelle Armenta Salas possesses extensive experience in clinical research and engineering, currently serving as the Principal Clinical Research Scientist at Ceribell, specializing in point-of-care EEG technologies. Previously, Michelle held the position of Clinical Research Engineer at Blackrock Neurotech and worked as a Research Scientist at Second Sight Medical Products. Michelle's academic foundation is solidified by a postdoctoral research role at Caltech, demonstrating a strong commitment to advancing neurotechnology and research methodologies.
This person is not in any teams
This person is not in any offices
Ceribell
1 followers
Ceribell is a fast growing venture-backed medical device start-up company founded by two faculty members at Stanford University. They have developed a highly innovative electroencephalography (EEG) device, which will make the diagnosis of neurological patients drastically more efficient.